T. Srokowski, J. Liebmann, M. Modiano
Nov 15, 2011
Citations
1
Influential Citations
19
Citations
Journal
Cancer
Abstract
Pixantrone dimaleate (pixantrone) has been shown to have antitumor activity in leukemia and lymphoma in vitro models and to lack delayed cardiotoxicity associated with mitoxantrone in animal models. FND‐R, a combination regimen of fludarabine, mitoxantrone, dexamethasone, and rituximab, has been shown to be an effective regimen for low‐grade lymphomas.